Copyright
©2013 Baishideng Publishing Group Co.
World J Hepatol. Aug 27, 2013; 5(8): 445-451
Published online Aug 27, 2013. doi: 10.4254/wjh.v5.i8.445
Published online Aug 27, 2013. doi: 10.4254/wjh.v5.i8.445
Table 1 Clinical, laboratory and histopathological characteristics of the studied patients n (%)
Parameter | HCV patients (n = 30) |
Clinical findings | |
Jaundice | 0 (0.0) |
Hepatomegaly | 4 (13.3) |
Splenomegaly | 1 (3.3) |
Ascites | 0 (0.0) |
Liver function tests | |
Total bilirubin (mg/dL) | 1.23 ± 1.051 |
Direct bilirubin (mg/dL) | 0.30 ± 0.26 |
Albumin (g/L) | 43.17 ± 7.5 |
Alanine transaminase (U/L) | 55.57 ± 126.16 |
Aspartate transaminase (U/L) | 72.10 ± 131.97 |
Gamma glutamyl transpeptidase (U/L) | 38.90 ± 21.92 |
Alkaline phosphatase (U/L) | 253.48 ± 97.38 |
Complete blood count | |
Hemoglobin (g/L) | 113.6 ± 11.2 |
White blood cells (× 103/ L) | 8.77 ± 7.52 |
Platelets (× 103/L) | 383.57 ± 390.87 |
Fibrosis stage | |
No (F0) | 1 (3.3) |
Mild (F1) | 12 (40) |
Moderate (F2-F3) | 17 (56.7) |
Activity grade | |
Minimal | 10 (33.3) |
Mild | 20 (66.7) |
Steatosis | 8 (26.7) |
Table 2 Histopathological findings in patients with normal vs elevated transaminases n (%)
Histopathology | Normal transaminases | Elevated transaminases |
Fibrosis stage | ||
No fibrosis (n = 1) | 1 (100) | |
Mild fibrosis (n = 12) | 5 (41.7) | 7 (58.3) |
Moderate fibrosis (n = 17) | 8 (47.1) | 9 (52.9) |
Activity grade | ||
Minimal activity (n = 10) | 5 (50) | 5 (50) |
Mild activity (n = 20) | 9 (45) | 11 (55) |
Table 3 Serum complement C4a according to different transaminases levels, viral loads and histopathological findings
Parameter | C4a (mg/L) | P value |
Fibrosis stage | 0.786 | |
No/Mild (n = 13) | 154.65 ± 20.59 | |
Moderate (n = 17) | 152.97 ± 17.72 | |
Activity grade | 0.809 | |
Minimal (n = 10) | 155.1 ± 21.93 | |
Mild (n = 20) | 152.99 ± 17.43 | |
Steatosis | 0.186 | |
Present (n = 8) | 146.13 ± 3.32 | |
Absent (n = 22) | 156.45 ± 21.19 | |
Normal transaminases (n = 14) | 155.36 ± 21.33 | 0.868 |
Elevated transaminases (n = 16) | 152.25 ± 16.62 | |
Viremia | 0.561 | |
Low viremia (n = 17) | 156.37 ± 18.91 | |
Moderate viremia (n = 9) | 152.43 ± 22.19 | |
High viremia (n = 4) | 145.2 ± 3.96 |
Table 4 Correlation of complement C4a with laboratory and histopathological parameters in liver biopsy
Parameter | C4a (mg/L) | |
r | P value | |
Total bilirubin (mg/dL) | -0.022 | 0.910 |
Direct bilirubin (mg/dL) | -0.038 | 0.841 |
Albumin (g/L) | 0.162 | 0.393 |
Alanine transaminase (U/L) | -0.148 | 0.332 |
Aspartate transaminase (U/L) | -0.026 | 0.891 |
Gamma glutamyl transpeptidase (U/L) | 0.000 | 1.000 |
Alkaline phosphatase (U/L) | 0.176 | 0.446 |
Hemoglobin (g/dL) | -0.100 | 0.599 |
White blood cells (× 103/L) | 0.054 | 0.777 |
Platelets (× 103/L) | 0.228 | 0.226 |
HCV-RNA (IU/mL) | -0.210 | 0.265 |
Fibrosis stage | -0.208 | 0.269 |
Activity grade | -0.114 | 0.548 |
- Citation: Behairy BE, El-Mashad GM, Abd-Elghany RS, Ghoneim EM, Sira MM. Serum complement C4a and its relation to liver fibrosis in children with chronic hepatitis C. World J Hepatol 2013; 5(8): 445-451
- URL: https://www.wjgnet.com/1948-5182/full/v5/i8/445.htm
- DOI: https://dx.doi.org/10.4254/wjh.v5.i8.445